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BACKGROUND
By 2025, it is predicted that more than 1.5 billion individuals worldwide will have
hypertension, accounting for up to 50% of heart disease risk and 75% of stroke risk.1 For
several decades it has been well known that lowering blood pressure (BP) with lifestyle
modification, medications, or both can substantially reduce a patient’s subsequent risk for
disease.2 For each 10-mm Hg decrease in systolic BP, the average risk of heart disease
mortality and stroke mortality decreases by 30% and 40%, respectively.3 Despite clear
benefits that treatment of hypertension reduces cardiovascular morbidity and mortality, only
half of those with hypertension have adequate BP control.4 There are many causes for poor
BP control besides lifestyle choices including sub-optimal patient medication adherence5-8
and failure to intensify therapy (clinical inertia) by clinicians.9, 10 One of the most effective
strategies to improve BP control is team-based care, especially with pharmacists and
nurses.11-13
This paper was commissioned by the Editorial Board of the Journal of Clinical Hypertension
for the American Society of Hypertension. We will review models of care delivery that are
driving health-care reform. We will then review key historical papers involving team-based
care strategies to improve blood pressure control with a focus on more recent controlled
trials and systematic reviews. Because there are hundreds of publications on team-based
care, this will not be an exhaustive review of the literature. Rather, this paper will focus on
rigorously designed controlled clinical trials, studies involving contemporary technology,
cost-effectiveness analyses and future models to improve BP control.
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The Chronic Care Model
The Chronic Care Model (CCM) was developed as a framework for redesigning healthcare
and addressing deficiencies in the care of chronic conditions, such as hypertension. Its 6
domains are decision support, self-management support, delivery design, information
systems, community resources, and healthcare systems. Optimizing and integrating these
domains has been shown to lead to activated patients, responsive healthcare teams, and
improved health services and treatment outcomes, and may be cost-effective (Figure 1).14-22
This model emphasizes the role of patients with chronic conditions as being their own
principal caregiver and the importance of provider, family, and community support in self-
management.14,23 In effect, patients are at the center of the care model with providers,
family, and community interacting in different ways to influence and support health
decisions. Collaborative care has been defined as: 1) collaborative definition of problems, 2)
goal-setting, planning and action plans, 3) a continuum of self-management training and
support services and 4) active and sustained follow-up.14, 15, 17-21, 24, 25 This model of care
recognizes a collaborative partnership between the patient, provider and the care team, each
with their own expertise in managing that person’s health, and who share in the decision
making process. This collaborative partnership between patient and provider is important in
supporting the patient’s management of chronic disease over multiple encounters and
adjustments in the treatment plan to achieve optimal care.
The Patient-Centered Medical Home and Teams
The patient-centered medical home (PCMH) was designed to replace episodic care based on
illness and patient complaints in order to provide ongoing “whole-person” comprehensive
chronic illness and preventive care.26 The PCMH is endorsed by the American Academy of
Family Physicians, American Academy Pediatrics, American College of Physicians, and is
broadly advocated as a potential vehicle for improving health care quality and mitigating
costs.27-29 In support, the National Committee on Quality Assurance (NCQA) has developed
a tiered set of recognition standards (Tables 1, 2). The PCMH emphasizes that patient care
be organized around the needs of the patient, their relationship with their personal physician,
and that physician-led teams may form and reform according to the needs of the
patient.24, 27 The physician delegates responsibility to other members of the team to perform
a medication history, identify problems and barriers to achieving disease control, perform
counseling on lifestyle modification and adjust medications following hypertension
guidelines. Frequent communication by team members concerning goal-directed therapy
allows the physician to address more acute problems and complications. There is early
evidence that the PCMH can be used to improve healthcare delivery outcomes, increase
physician satisfaction, and decrease the costs of healthcare.30, 31 The personal relationship
between the patient, physician, and the team has also been used to overcome barriers to care
often seen in minorities or other vulnerable populations.32
Historical Context and Systematic Reviews
Several key studies published prior to 2000 will be discussed. A more comprehensive list of
controlled trials of team-based care can be found in the systematic reviews which are also
discussed below.
The first study of team-based care was published in Circulation in 1973 by McKenney et
al.33 Patients (n=50) were randomized to traditional pharmacy services or an intervention
group. The community pharmacist evaluated patients and worked closely with two
physicians in an urban health center in Detroit including visiting the clinic to review the
medical records and the pharmacist made recommendations for changes in therapy. Patients
in the intervention group were seen monthly for five months by appointment with the
pharmacist in one of three community pharmacies. BP was measured in the physician’s
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office and it deteriorated in the control group from 163/93 mm Hg to 166/101 mm Hg over
the 5 months. However, BP improved in the intervention group from 157/99 mm Hg at
baseline to 146/90 mm Hg (between group p<0.001). BP control deteriorated in the
intervention group once the intervention was discontinued.
Bogden and colleagues (1998) evaluated the effect of a pharmacist working within a medical
resident teaching clinic.34 Patients with uncontrolled hypertension were randomized to
either a control (n=46) or intervention (n=49) group. Systolic BP decreased 23 mm Hg in the
intervention group and 11 mm Hg in the control group (p<0.001). BP control was achieved
in 55% in the intervention group compared to 20% in the control group (p<0.001).
Borenstein et al. (2003) evaluated physician-pharmacist co-management of hypertension
within an integrated healthcare system.35 Patients were randomized to either the co-managed
group (n=98) that attended a hypertension clinic run by pharmacists or usual care (n=99).
Patients were seen every 2 to 4 weeks, with the pharmacist calling the physician at each visit
with the recommended treatment plan based on an evidence-based algorithm. Systolic BP
was reduced significantly more in the co-managed group than in the usual care group at 6, 9
and 12 months (22 vs. 9, 25 vs. 10 and 22 vs. 11 mm Hg, respectively, p<0.01 at all time
points). More patients in the co-managed group (60%) achieved BP control than in the usual
care group (43%, p=0.02).
One of the earliest published studies of nurses (Logan et al., 1979), was conducted in the
patient’s workplace and compared BP to a control group managed by the patient’s family
physician.36 In contrast to the study by Borenstein et al, the nurses prescribed and changed
drug therapy without physician approval while physicians reviewed the charts of nurse-
managed patients on a weekly basis. The study involved 457 participants and nurse-
managed patients were more likely to receive a new antihypertensive (95% vs. 63%,
p<0.001), receive two antihypertensives (44% vs. 18%, p<0.001), more likely to adhere to
the medication regimen (68% vs. 49%, p<0.005) and more likely to achieve goal BP at 6
months (49% vs. 28%, p<0.001).
Rudd and colleagues (2004) conducted a randomized controlled trial (RCT) comparing
nurse case-management (n=74) to a control group (n=76).37 Nurses saw patients at baseline
and provided education on use of an automated BP device, strategies to improve medication
adherence and identification of adverse drug events. The nurses performed additional
telephone contacts at 1 week and at 1, 2, and 4 months, independently made medication
dosage increases, and contacted the physician to obtain permission to initiate any new BP
medication. Of note, only patients randomized to nurse case management received portable
BP monitors which could have further improved BP control independent of nurse functions
due to greater patient self-monitoring. Systolic BP declined by 14.2 mm Hg in the
intervention group and 5.7 mm Hg in the control group (p<0.01) at 6 months. Patients were
taking significantly more medications in the intervention group and had significantly more
medication changes (223 vs. 52, p <0.01) than the control group. Medication adherence at 6
months was 81% in the intervention group and 69% in the control group (p=0.03).
An interesting study conducted by Mundinger and colleagues evaluated care of several
conditions including hypertension delivered by nurse practitioners compared to
physicians.38 Most patients were Hispanic immigrants and all patients were enrolled after an
emergency department or urgent care visit who were randomized to either a nurse
practitioner (n=806) or a physician (n=510). The nurse practitioners and physicians had
interchangeable roles for prescribing, consulting, referring or admitting patients and the
primary outcome was quality of life which was no different between groups. Diastolic BP
was slightly better when provided by nurse practitioners compared to physicians (137/82 vs.
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139/85 mm Hg, p=0.28 for systolic and p=0.04 for diastolic BP) over a period of one year
after baseline.
Several systematic reviews have been conducted to evaluate various quality improvement
strategies to improve BP control. Walsh and colleagues prepared a report for AHRQ and
subsequently published their findings in 2006.11 They identified 63 controlled studies of
quality improvement (QI) strategies directed at improving hypertension control.11 The
majority of the studies combined several strategies and a taxonomy was developed for
categorizing various QI approaches. Median systolic BP reductions for various approaches
were: audit/feedback (1.3 mm Hg), provider education (2.7 mm Hg), provider reminder
systems (6.8 mm Hg), self-management (3.6 mm Hg), patient education (8.1 mm Hg), and
organizational change (10.1 mm Hg). These authors found that the only statistically
significant effects occurred with organizational change, which included team-based care (37
comparisons) where they found a median reduction in systolic BP of 9.7 mm Hg and a
21.8% net increase in systolic BP control.
Another meta-analysis of pharmacy based interventions was performed by Machado et al.
(2007).39 These authors evaluated 13 studies that included 2200 individuals and found that
pharmacists’ interventions significantly reduced SBP (10.7 SD 11.6 mm Hg; p = 0.002),
while controls remained unchanged.39 These findings confirm the findings of other meta-
analyses and systematic reviews.
Another meta-analysis of team-based care by Carter and colleagues (2009), evaluated the
potency of either nurse or pharmacist-assisted management of hypertension.12 This analysis
found significantly greater likelihood of controlled BP in studies involving nurses (OR =
1.69; 95% CI=1.48-1.93), pharmacists within clinics, (2.17; 1.75-2.68) and community
pharmacists (2.89; 1.83-4.55) compared to usual care. These authors attempted to isolate the
components of team-based care that were most effective and found the reductions in systolic
BP (in mm Hg) were: pharmacist recommended therapy to the physician (−9.3), patient
education provided by nurse or pharmacist (−8.8), pharmacist performed the intervention
(−8.4), medication adherence assessed (−7.9), nurse conducted the intervention (−4.8),
treatment algorithm was used (−4.0).
In the most recent Cochrane review (2010) of quality improvement interventions used to
improve control of BP in patients with hypertension,40 72 randomized RCTs were identified
representing the following six intervention types: (1) self-monitoring; (2) educational
interventions directed to the patient; (3) educational interventions directed to the health
professional; (4) health professional (nurse or pharmacist) led care; (5) organizational
interventions that aimed to improve the delivery of care; and, (6) appointment reminder
systems. Self-monitoring was associated with modest net reduction in systolic (S) BP
(Weighted Mean Difference (WMD) −2.5 mmHg, 95% CI: −3.7 to −1.3 mmHg) and
diastolic (D) BP (WMD −1.8 mmHg, 95% CI: −2.4 to −1.2 mmHg). Trials of educational
interventions directed at patients or health professionals appeared unlikely to be associated
with large net reductions in BP by themselves. Appointment reminder systems were
heterogeneous and results were not clear, but the majority of trials increased the proportion
of individuals who attended follow-up visits by almost 2.5 times and in two small trials also
led to improved BP control (odds ratio 1.85, 95% CI 1.37 to 2.44) favoring the
intervention 40 The Cochrane review authors conclude that an organized system of
registration, recall and regular review allied to a vigorous stepped care approach to
antihypertensive drug treatment appears the most likely way to improve the control of high
BP.41 They also concluded that nurse or pharmacist led care was promising, with the
majority of RCTs being associated with improved BP control and reduction in mean SBP
and DBP.
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Chisholm-Burns and colleagues (2010) conducted a meta-analysis and identified 298 studies
trials in the US that evaluated pharmacist-provided direct patient care for various chronic
conditions.13 These authors found significant improvements in BP, HgA1c, low density
lipoprotein cholesterol, adverse drug events, medication adherence, quality of life and
patient knowledge (p<0.05).
In a recent systematic review and meta-analysis by Clark and colleagues (2011), of trials of
nurse-led interventions for hypertension in primary care focused on establishing whether
nurse prescribing is an important intervention.42 Interventions that included a stepped
treatment algorithm showed greater reductions in SBP (weighted mean difference −8.2 mm
Hg, 95% CI −11.5 to −4.9) compared to usual care. However, this was not associated with
higher achievement of BP targets. Nurse led clinics with structured prescribing algorithms in
primary care settings also achieved greater reductions in SBP and DBP compared with usual
care. Interestingly, when results were pooled, nurse led interventions significantly lowered
SBP compared to usual care in African Americans participants, but there was little
difference for other ethnic minority groups. In general, this review suggests that
hypertension care led by a nurse leads to improvements in BP compared to doctor-led or
usual care.42
Limitations of Previous Studies and Gaps in Knowledge
The above studies highlight the consistent benefit of team-based care for improving BP
control. However, the authors of the systematic reviews and others identified several
limitations in the published literature including:43, 44 small patient sample sizes, single or
few pharmacist or nurse interventionists, lack of a control group, lack of intention-to-treat
analyses, and not controlling for potentially confounding covariates. Randomization does
not always eliminate all differences between groups, particularly for studies with smaller
sample size. Therefore, covariates such as gender, race, education, baseline BP and body
mass index should be controlled in the analyses. Generally, studies were conducted at single
sites, leading to potential contamination if the intervention included changing provider
behavior and the clinician had patients in both control and intervention groups. An
advantage of limited number of medical offices or intervention providers is the ability to
maintain high fidelity of the intervention. However this might also make results less
generalizable. Additionally, in some studies the measurement of BP was biased, because the
measurement was made by the intervention provider or person invested in the results and
thus not blinded. In other studies, unreliable BP measurements (e.g. routine office readings)
were used as the outcome variable.
In defense of investigators, the funding sources for team-based care interventions prior to
2000 was limited and large, rigorously trials were difficult to conduct. With increased
interest in translation and health care reform, such funding has become available and recent
and ongoing studies are addressing some of the key gaps in our understanding of team-based
care including:
There remain numerous gaps in our understanding of team-based care, some of which will
be addressed in more recent and ongoing studies we discuss below. Some of these gaps in
the literature include:
1. Most studies had durations of 12 months or less and longer-term effectiveness was
not evaluated.
2. Little information was available on the sustainability of the intervention once it was
discontinued.
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3. Because typical team interventions might change provider behavior, it is not known
how much the positive effects on BP diffuse to other patients in the practice who
are not directly involved in the study intervention. Understanding the larger
contextual, organizational impacts of such team interventions is essential,
particularly when trying to instigate individual provider quality improvement
feedback or use of “pay for performance” strategies.
4. Very few cost-effectiveness analyses have been published and the relative costs and
benefits must be better defined. We do not have an adequate understanding of what
outcomes should be measured in cost analyses, nor what would be considered a
reasonable return on investment.
5. Few studies have actually evaluated a typical team that might be formulated in
primary care practices, that might not have access to in-house or clinical
pharmacists or nurses or payment systems that would allow clinicians to provide
this type of care. Alternatively, larger integrated healthcare organizations might be
able to form multi-provider teams that include social workers, nutritionists, and
hypertension specialists.
6. There is no information on when the patient care team should engage a
hypertension specialist or how the specialist could be integrated into this team.
7. The most efficient utilization of team members has rarely been evaluated. When
and how to engage the specific expertise of various team members needs better
definition. Few studies have examined the use and acceptability of nurses and
pharmacists following medication algorithms to make direct medication changes.
8. Several studies of team-based care have used various technologies and/or self-
monitoring. However, far more research is needed to evaluate web-based
approaches, the use of social media and other strategies to better engage patients in
their own care.
9. Models for reimbursement and subsequent sustainability of programs have not been
adequately examined.
Contemporary and Ongoing Studies 2005-2014
More recent studies have begun to address some of the limitations of previous studies and
gaps in the literature of team-based care. This section will briefly review some of these key
studies.
A. Randomized trials of pharmacists—Lee and colleagues conducted the Federal
Study of Adherence to Medications in the Elderly (FAME), which was a multiphase study
conducted at Walter Reed Army Medical Center in 200 patients taking 4 or more various
medications, 92% of whom had hypertension.45 Following a run-in phase, all patients
received a comprehensive pharmacy program to improve adherence including education and
a pre-packaged medication adherence aid (blister packs). After 3-8 months in Phase 1,
subjects were randomized to usual care or continued pharmacy care for an additional 6
months. Patients randomized to usual care once again received traditional pill bottles with
90 day supply. Patients randomized to pharmacy care continued to receive follow-up every 2
months by the pharmacists plus medication blister packs to improve adherence. Following
the Phase 1 period with blister packs and pharmacy care, systolic BP improved from 133.2 +
14.9 mm Hg to 129.9 + 16.0 mm Hg (p=0.02). However during phase 2, systolic BP
deteriorated back to baseline in those returning to usual care (133.3 + 21.5 mm Hg) but
improved further in those receiving the continued intervention (124.4 + 14.0 mm Hg,
Carter et al. Page 6













p=0.005 between groups). It is unclear from this study whether the unit dose packaging, the
pharmacist or both contributed to the success of the intervention.
Carter and colleagues conducted a cluster, randomized trial (randomized clinics) with 179
patients enrolled into a 9-month study intervention.46 Research nurses measured BP at
baseline, 2, 4, 6 and 9 months. Ambulatory 24-hour BP was measured at baseline and 9
months. Pharmacists employed in the medical offices made specific recommendations to
physicians and patients to improve BP control. The majority of recommendations were to
intensify medications.47 The mean adjusted difference in systolic BP was 8.7 (95% CI: 4.4,
12.9) mm Hg in favor of the intervention group, and the difference in diastolic BP was 5.4
(CI: 2.8, 8.0) mm Hg. The 24-hour BP levels were a mean systolic BP reduction of 8.8 (CI:
5.0, 12.6) mm Hg and diastolic BP 4.6 (CI: 2.4, 6.8) mm Hg in the intervention group
compared to the control group. BP goal was achieved in 89% of patients in the intervention
group and 53% in the control group (adjusted odds ratio 8.9; CI: 3.8, 20.7; p<0.001). After
this study was completed, these investigators performed a retrospective evaluation of a
sample of 103 of these patients who agreed and re-consented had BP values at baseline and
9 months during the intervention and then at 18 and 27 months after baseline (9 and 18
months following discontinuation of the intervention).48 This sample of patients was similar
to the larger study sample. By 27 months (18 months after the intervention was
discontinued), systolic BP was 132.7 + 11.5 and 143.0 + 12.2 mm Hg (p<0.001) and BP
control was 59% and 31% in the intervention and control groups, respectively (p=0.0048).
This study suggests that the relatively short-term intervention had long-lasting effects.
In a second cluster, randomized trial (Carter et al.) was conducted in six family medicine
medical offices in Iowa.49 The study randomized the offices to control or intervention
groups and 402 patients with uncontrolled hypertension entered the six month study period.
Clinical pharmacists on the staff of these offices made drug-therapy recommendations to
physicians based on national guidelines. Research nurses performed BP measurements and
24-hour BP monitoring. The adjusted difference in systolic BP was −12.0 (95% CI: −24.0,
0.0, p<0.05) mm Hg between intervention and control group at 6 months. The 24-hour BP
levels showed similar differences between groups. BP was at goal in 29.9% of patients in the
control group and 63.9% in the intervention group (adjusted odds ratio 3.2; CI: 2.0, 5.1;
p<0.001). These authors also conducted a retrospective evaluation to determine whether the
intervention effect could be sustained once it was discontinued.50 Even after 18 months
following discontinuation of the intervention BP was 130.0 + 16.0 mm Hg in the
intervention group and 138.1 + 20.4 mm Hg in the control group (p=0.0023). BP was at goal
in 67% of patients in the intervention group and 36% of those in the control group
(p<0.001). This study also suggests that this 6-month pharmacist intervention had long-
lasting effects, probably related to medication adjustments that resulted in persistent BP
control.
Recently Bosworth and colleagues have initiated a VA funded study focusing on
cardiovascular disease (CVD) risk with a focus on medication management (e.g., BP, a1c,
lipids, blood clotting) and behavioral outcomes (e.g., medication adherence, exercise),
administered by a pharmacist over the telephone. This study will take place within two VA
primary care clinics. The intervention is tailored to the needs of vulnerable high risk patients
and addresses multiple CVD-related behaviors and medication management risk. The study
will enroll 500 patients with cardiovascular disease who will be randomized to either the
education control group or the intervention group. Patients randomized to the intervention
group will receive a clinical pharmacist-administered intervention, which focuses on
behavioral and a medication management. Given the national prevalence of CVD and the
dismal rates of risk factor control, interventions such as the one proposed could improve
secondary prevention of CVD in the VA.
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B. Controlled trials of nurse interventions—There is a reasonable and growing body
of literature that nurses can significantly improve hypertension outcomes. As mentioned
previously, a recent review of studies from 2005-2009 was conducted of 33 randomized
controlled trials that included an intervention delivered by nurses, nurse prescribers, or nurse
practitioners designed to improve blood pressure, compared with usual care. Compared with
usual care, interventions for hypertension achieved higher degrees of blood pressure targets
when they included a stepped treatment algorithm by a nurse, nurse prescribing, or a nurse
leading telephone monitoring.42
Case management by a nurse-led team has been shown to be efficacious strategy to improve
management of cardiovascular risk factors including hypertension management in many
studies.51, 52 Nurses, for example, have demonstrated successful strategies for improving
blood pressure by serving as a bridge to physician care and by adhering more strictly to
management algorithms, including many counseling features that may not necessarily be
within the time frame of a busy physician in practice.12, 37, 52-57 More recent studies that
involved nurses within team-care are discussed below.
Extending Beyond Traditional Clinical Settings
Improving patients’ hypertension management behaviors, and medication adherence, while
critically important, can be complex and time-consuming. In a typical primary care setting
time limitations, competing demands, the burden of co-morbid illness, along with
inadequate mechanisms for follow-up, all constitute barriers to effective hypertension risk
factor management. Perhaps for these reasons, prior interventions that sought to influence
physician medication prescribing in a clinic setting have been mostly ineffective. Most
aspects of hypertension risk reduction, however, do not require a physical examination, and
BP can be measured at home, thus much of the care of hypertension could be accomplished
outside of the traditional confines of office-based clinical care. Telemedicine or remote
monitoring in patients’ homes has been offered as a plausible solution to improving
ambulatory medical care. However current reimbursement models do not encourage these
in-person and remote primary care interventions.
Telemetry can be used to transmit BP measurements taken at home into a data repository
where it can be used to generate paper reports or linked to other data systems. Telemedicine
refers to interactive communications which can be as simple as telephone based-care, or
interactive video and digital technologies, enabling direct communication between patients
and their care team from remote sites. Automated interactive voice response (IVR) uses
computer technology to telephone patients, collect data, and provide tailored interventions
based on their responses. Team-based applications of these technologies are described
below.
A. Telephone Interventions—Clinical inertia, the phenomenon of physicians failing to
intensify medication regimens at encounters with patients who have uncontrolled risk
factors, has been cited to potentially account for a significant proportion of CVD
events,10, 58 suggesting that alternative methods for interventions may be needed. Also,
clinic visits are primarily focused on symptom management, leaving little time for
comprehensive risk factor management. An intervention that is delivered in patients’ homes
may be more successful in non-symptom based approaches to healthcare.
Telephone contact offers one possibility to reduce healthcare barriers. Telephone contact has
been shown to be effective in changing multiple patient behaviors.59-62 Telephone
interventions also allow more patients to be reached and these interventions may be more
acceptable and convenient than in-person interventions.63 Delivering an intervention by
telephone may enhance the interventions’ cost-effectiveness, primarily due to reduced
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intervention costs and reduced visit rates coupled with the clinicians’ ability to follow a
much larger panel over which to spread fixed intervention costs than would be possible with
an in-person intervention. Thus, the use of telephones to implement the intervention allows
individualized, personal interaction at minimal cost and without the time and transportation
barriers that accompany in-person programs. This personal interaction allows the
intervention to be adapted and tailored to participants’ current concerns, health goals, and
specific barriers to achieving these goals.
Bosworth et al completed the Take Control of Your Blood Pressure Study (TCYB) in which
hypertensive patients (n=636) were randomized to one of four groups: usual care; a nurse-
administered behavioral intervention; home BP monitors alone; or, a combination of the
behavioral intervention and home BP monitors. Patients were highly adherent in recording
their home BP values. A majority of the 318 patients in the nurse arm received all 12
intervention encounters and completed the 24-month follow-up. Patients randomized to the
combined group had the greatest improvement in BP control (70% to 83% at 24 months;
17% relative usual care; p=.01 and SBP (improved by 6 mm Hg relative to the control
group) at 24 months.54 The average cost of the combined intervention was $416 per patient
over 24 months.54 In sub-analyses, at 24 months, in the combined intervention, non-whites
had sustained lower SBP as compared to usual care (7.5 mm Hg; p<0.02).64
B. Health Information Technology Interventions—Dramatic advances in health
information technology (HIT), including electronic health records (EHRs), and high speed
communications, provides new opportunities for improving the care of chronic conditions,
including hypertension. HIT is an integral part of proposed models to reform healthcare,
including the Chronic Care Model,17, 19, 65 and the Patient-Centered Medical Home.27-29, 66
Additionally, the Institute of Medicine’s blueprint for meeting the Crossing the Quality
Chasm67 goals for delivering of state-of-the art health care suggests that patients should
receive care when they need it and in many forms, have unfettered access to their own
medical information and that there should be active collaboration and information exchange
between clinicians”. In this section we describe results of studies that have used these new
technologies as tools and strategies to support team-based care for hypertension.
Artinian offered free BP screenings to African Americans at various community sites and
those with uncontrolled BP and a land-line telephone were randomized to enhanced usual
care (UC), including education and identifying resources for receiving medications and
clinical care, or this intervention plus home BP monitoring (HBPM), and nurse managed
telemetry.68 Nurse-telemetry patients were asked to measure their BP 3 times a week.
Subjects uploaded BP data by attaching the HBPM to a modem unit which automatically
dialed a data repository managed by a service independent from the patient’s regular clinical
care. Formatted BP reports were reviewed by a registered nurse who called the patient and
provided medication and lifestyle counseling. Doctors received a copy of the telemetry
report, and they could request the patient come in for an appointment if needed. At 12
months the telemetry nurse group had significantly decreased systolic BP compared to
enhanced usual care (net difference −5.5 mm Hg (P=.04)) with non-significant differences
for diastolic BP. Change in BP control was not reported. The cost of the telemetry service
was $1.50 a day. Nurse telephone feedback and counseling took between 7 and 16 minutes
per call, which initially occurred weekly, then monthly during the last months of the
intervention.
Bosworth56 has recently completed and Margolis69 has an ongoing study that combines
HBPM with a modem to send BP data, combined with nursing care (Bosworth) or
pharmacist management (Magolis). Bosworth examined which of three interventions was
most effective in improving BP control over 18 months.70 Eligible patients were randomized
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to either usual care or 1 of 3 telephone-based intervention groups: (1) nurse-administered
behavioral management, (2) nurse- and physician-administered medication management, or
(3) a combination of both. The intervention telephone calls were triggered based on home
BP values transmitted via telemonitoring devices. Behavioral management involved
promotion of health behaviors. Medication management involved adjustment of medications
by a study physician and nurse based on hypertension treatment guidelines. Both the
behavioral management and medication management alone showed significant
improvements in BP control, 12.8% (95% CI: 1.6%, 24.1%) and 12.5% (95% CI: 1.3%,
23.6%), respectively, at 12 months, but there was no difference not at 18 months. In a
subgroup analyses, among those with poor baseline BP control, systolic blood pressure
decreased in the combined group by 14.8 mm Hg (95% CI: −21.8, −7.8) at 12 months and
8.0 mm Hg (95% CI: −15.5, −0.5) at 18 months, relative to usual care.
Magid in a recently published study coupled IVR with pharmacist care-management.71
Patients with hypertension, receiving antihypertensive medication, and with uncontrolled BP
were identified using electronic medical records (EHRs) and invited to a screening visit.
Those with uncontrolled BP at the screening visit were randomized to receive IVR enhanced
pharmacist care management or usual care (UC). The IVR pharmacist care group received
computer calls weekly asking them to enter their BP using the touch-tone keypad. They
received feedback as to their average BP and the opportunity to listen to a hypertension-
related educational message. Clinical pharmacists reviewed home BP data, EHR medication
adherence, and made medication changes if needed using a pre-approved protocol.
Pharmacists contacted patients by telephone and patients’ physicians by progress note in the
EHR. After 6 months BP control was not significantly different between the 2 groups,
however systolic BP was significantly lower in the IVR pharmacist group (net change −6.0
mm Hg, P=.006), but differences between groups deteriorated, and based on chart review of
BP measurements 6 months after the intervention was completed (12 months after baseline).
Over 90% of the patients uploaded at least one set of BP measurements, but information on
persistence of communications was not provided. A potential concern with IVR is hang-ups;
however the pharmacist attempted to call the patient if the patient did not respond after
repeated IVR attempts and a reminder. A particular strength of this IVR pharmacist
approach was that the pharmacist only needed to interact with patients with uncontrolled BP.
Cost of the intervention was not reported. IVR systems vary greatly in costs depending on
the sophistication of the computer model, logic systems used, length of the interactions, and
number of follow-up attempts made if the patients are not initially contacted.
Shea in the IDEATel study randomized underserved ethnically diverse older patients with
diabetes to either receive a nurse-telemedicine unit or usual care.72, 73 The telemedicine unit
computer had four functions: synchronous videoconferencing, Web access, and home BP
and glucose monitors that could be connected to the unit. Communications were enabled via
a modem connected to telephone line. Nurse case managers trained in diabetes care and
supervised by diabetologists provided care via videoconference visits, secure-e-mail, clinical
data review, computer reminders, alerts, and automated quality assurance reports, and
patient chat groups. For patients not at recommended targets for diabetes, including BP, a
change in management was recommended to the patient’s physician by e-mail, fax, or
phone. Those receiving the telemedicine-nurse intervention had significant decreases in both
systolic and diastolic BP compared to usual care at the 1 and at 5 year follow-up
assessments (net change at 5 years – 4.3 mm Hg (−1.9,−6.7) and −2.6 mm Hg (−1.5,−3.7)
respectively).
Bove enrolled inner-city (Temple University Medical Center) predominantly African
Americans and rural Caucasians (Geisinger Medical Center) with a > 10% risk of
cardiovascular disease.74 Patients were randomized to receive either research nurse
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management with 4 visits in one year or this plus receipt of telemedicine computer and
access to a personal health record in which they could review their medication list and
laboratory results, upload HBPM, weight, and pedometer data weekly, and receive secure
messages. Patients received by telemedicine computer system and mail, and their physicians
by fax, summaries of their BPs, lipids, and their overall CVD risk and recommended targets,
which were discussed at the 4 nurse management visits. All patients reduced their BP and
risk of CVD, however there was no difference between intervention groups. While
physicians received faxed reports of BP, nursing care was not integrated directly into patient
care.
C. Personal Health Records and Patient Web Portals—Patient-controlled electronic
personal health records and secure patient Web portals linked to EHRs offer patients and
health care teams opportunities to share health data and communicate asynchronously. Grant
et al randomized primary care practices and their patients with diabetes and an HbA1c
>7.0% to receive a Web-based personal health record designed for the study or usual care
(UC).75 These authors found that encouraging patients with diabetes to use the module did
not lead to significant decreases in BP or improvements in BP control. However the module
was developed specifically for the study, providers were not used to using this module, and
patients did not receive team care assistance from a pharmacist or nurse.
Green and colleagues conducted the Electronic Communications and Home BP Monitoring
Study (e-BP) in an integrated healthcare system with an existing EHR linked to a secure
patient Web portal.76 This study randomized patients with uncontrolled hypertension, access
to the Web, and an e-mail address to either (1) UC, (2) this plus a HBPM and a onetime
training session on use of the existing patient Web portal and encouragement to use these
tools to communicate with their physician to get their BP in control, or (3) this plus Web-
based collaborative pharmacist care – using the existing patient shared EHR including
asynchronous secure e-mail communications. Pharmacists used an approved protocol to
make medication changes, contacted the patient’s physician for clinical concerns or any
medication issues not addressed in the protocol, and documented all care processes in the
EHR. Patients receiving the HBPM-Web only intervention had a small, but significant
decrease in systolic BP (net change −2.9 mm Hg, P=.02) but diastolic BP and BP control
was not significantly improved compared to UC. In contrast, patients receiving Web-
pharmacist care had significant decreases in systolic and diastolic BP, and improved BP
control compared to both UC and Web only (compared to UC, net change systolic and
diastolic BP −8.9 mm Hg (P<.001) and −3.5 mm Hg (P<.001) and net improvement in BP
control was 25% (P<.001)). Medication intensification and secure e-mail significantly
increased in the Web-pharmacist group. Long-term changes in BP after the intervention
ended and cost-effectiveness are being studied. Of note, in the e-BP study, HBPM data was
not electronically uploaded into the EHR. Patients had to manually enter their BP
measurements into secure e-mail messages. EHRs have the capacity to interface with
telemetry data, but we are unaware of this being done currently in clinic settings. The e-BP
study provides evidence that HBPM and the ability to send secure e-mail to your health care
team, may lead to small improvements in BP, however combining this with team care led to
more robust changes.
Similarly in an Evidence Report and Technology Review, Barriers and Drivers of Health
Information Technology Use for the Elderly, Chronically Ill, and Underserved, sponsored by
the Agency for Healthcare Research and Quality (AHRQ), information technology
interventions were consistently effective if they included “complete feedback loops”.77
Complete feedback loops included monitoring of the patient’s current status, interpretation
of this based on treatment goals, adjustments of the management plan, communicating of the
recommendations back to the patient, and this cycle being repeated at appropriate intervals.
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This type of complete feedback loop is particularly well supported by team-based care.
Saver and colleagues are currently conducting a study testing whether use of a HBPM with
data sent to an EHR via a patient owned personal health record (HealthVault), combined
with team-care delivered by a nurse, can be used to improve BP control in patients with
diabetes and uncontrolled hypertension.
It is unknown the degree to which web-based communication coupled with a web-based,
tailored disease management and education program improves risk factor control beyond
traditional telemedicine disease management provided by health care personnel. To this end,
Bosworth and his colleagues are carrying out a study involving a telemedicine intervention
to improve achieving goals for cardiovascular risk factors, particularly improvements in
systolic blood pressure, among individuals who have had a myocardial infarction. To
evaluate this intervention, 450 patients with a recent myocardial infarction and hypertension
will be enrolled into a 3-arm randomized, controlled trial. The first arm (n = 150) will
receive home blood pressure (BP) monitors plus a nurse-delivered, telephone-based tailored
patient education intervention and will be enrolled into Heart360, the American Heart
Association’s interactive web-based health monitoring tool. The second arm (n=150) will
also receive home BP monitors plus a tailored patient education intervention and be enrolled
in Heart360. However, the patient education intervention will be delivered via a web-based
program and will cover identical topics as the nurse-delivered intervention. Both arms will
be compared with a control group receiving standard care (n = 150). All participants will
have an in-person assessment at baseline and at the completion of the study, including
standardized measurements of BP, low-density lipoprotein (LDL-C), and HbA1c (in diabetic
subjects). The study will compare the cost, scalability and effectiveness of two interventions
modes compared to use care.78
D. Texting and Smart Phone Web Communications—Patients can increasingly
access the Web via smart phones using wireless or high speed radio wave connections.
Texting services, however require only standard radio wave connections, and can be
accessed using Short Message Services. Both provide new opportunities for patients to
communicate with their health care team. Park in a small quasi-experimental study
conducted in Korea, provided obese patients with hypertension access to a Web site via a
computer or usual care.79 Patients entered BP, weight, and other data into the Web site from
their computer or a cell phone weekly. A supervised research nurse reviewed the data and
sent back tailored feedback to the patient via both the Web site and via cell phone using a
Short Message Service and text messages. After 8 weeks, systolic and diastolic BP and
weight were significantly decreased in the active group compared to controls (net change
−9.1 mm Hg (P<.05), −7.2 mm Hg (P<.05), and −1.6 kg (P<.05) respectively). We are
unaware of any studies that are currently using Smart Phones (such as the i-Phone or
Android) applications as a tool for team-care based hypertension care, however we expect
that any virtual care that health care systems currently provided over the Web could be used
on Web enabled phone or other types of electronic communications systems.
E. Technology and Potential Disparities—It is important to note that some people do
not have access to, or the financial resources to purchase computers, Web access, or land
line and cellular telephones. Additionally some people cannot use technology tools or
services because of low literacy or lack of translation between different languages. Careful
attention to the needs of these groups will be needed, or the disparities that already exist in
relation to computer access, hypertension control, and cardiovascular outcomes will
worsen.80 Finkelstein and colleagues have developed and are testing low cost computers that
are linked to monitoring devices and remote communications that can be use by people with
low literacy skills.81 Other options include allowing patients to have walk-in access to
kiosks at clinics and if needed being assisted by medical assistants, or enlisting community
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health workers or family member caretakers (such as the children of elderly people) to assist
with self-monitoring and electronic communications at communities centers or home.
Alternatively, patients frequently access computers at local libraries, community centers or
other locations. Patients might also have different preferences for the types of
communications they prefer.
F. Technology and the Future of Team Care—Demand for new patient-centered HIT
applications for improving patient self-care and virtual communications between patients
and their health care team is increasing. New and ongoing studies will help to learn the most
effective approaches for improving hypertension care. Smart phones, cell phones, blue tooth,
texting, personal health records, patient portals, electronic computer games are basically the
same – computers linked to electronic communications. Depending on user-needs, all have
the potential to be used for self-monitoring and communications between patients and
healthcare teams. Electronic games could be used to assist patients with self-care
management – monitoring BP, medication adherence, and lifestyle change. HIT can be
translated and used in all languages and adapted to assist people with disabilities.
Larger healthcare systems are increasingly acquiring patient Web portals for a variety of
business reasons other than just improving hypertension care. However adoption of these
systems in smaller community practices may lag because of the investment required and the
inability to recoup this as a billable service. Incentives made possible by the HITECH bill,
the PCMH and Accountable Care organizations provide new opportunities for use of these
technologies to enhance team care.
Summary of technological issues
Studies that have utilized HIT and high speed communication technologies provide new
ways for patients and their health care teams to electronically share BP measurements,
medications, and lifestyle behaviors information, outside of office visits allowing
opportunities for providing feedback and adjustment of care plans. Results that have
combined electronic technologies with team care havehad the most positive results, but the
studies are heterogeneous. Little is known about the optimal dose of strategies and their
cost-effectiveness. Additionally there is no information on the long-term benefits of
technology enhanced team interventions, to what degree BP control is maintained over time,
whether continuous or booster interventions are needed, and their long-term effect on
cardiovascular outcomes, quality of life, and the costs of health care. Results from ongoing
and new studies will provide important information on the most efficacy and value of these
strategies.
Cost-effectiveness analyses
From the perspective of the health care system, with BP reduction as a goal, understanding
the relationships between interventions and medical costs and their effects on blood pressure
is necessary in making informed program funding decisions. From the perspective of the
patient, time is a limited resource that should be expended on activities that yield
improvements in health outcomes. However, there have been few studies to examine the
short and longer-term cost effectiveness team-based interventions to improve hypertension
care. Short-term costs include the costs of the intervention, and offsets or additional costs as
realized by changes in healthcare utilization. Long-term costs take into account benefits and
costs accrued over time in terms of programmatic costs (depending on whether team care is
provided one time, intermittently, or ongoing), and hypertension-related outcomes, where
from a patient and societal perspective most benefit would be expected to occur. We review
below studies that have reported either direct costs or cost-effectiveness of team-based
interventions to improve hypertension control.
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Investigators from the V-STITCH estimated that the mean annual total intervention cost per
patient was $112 and ranged from $61 to $259 per patient depending on the nurse’s salary,
the number of patients that the nurse can manage, and what indirect costs are allocated to the
intervention.82 Nonetheless, even at the maximum value, the intervention cost represents, at
most, 3% of the total cost that a given hypertensive veteran incurs over a 2-year period.
Lastly, intervention cost could be lowered substantially if a less expensive care provider was
used to implement the behavioral intervention. The TCYB study demonstrated statistically
and clinically significant reductions in blood pressure with a tailored behavioral intervention
when combined with home blood pressure monitoring. However, these interventions are
cost-additive to the health care system. Thrice-weekly blood pressure monitoring resulted in
patient time costs that surpassed the cost of the intervention.83
These results support the findings of two previous studies that showed that a telephone-
based hypertension intervention can be implemented at reasonable cost and be potentially
cost-effective. In study of Friedman et al,60 an interactive computer-based
telecommunication system was used to communicate with patients in their homes between
office visits. They estimated a 6-month intervention cost of $32.50 per patient, which would
be $96 in 2005 dollars. As effectiveness measures, their telephone intervention use led to an
improvement in medication adherence and reduction in SBP. In a study by Bertera et al,
usual care was compared with telephone counseling or face-to-face counseling.84 Patients in
either counseling arm received counseling sessions every 3 weeks for 6 months that covered
a number of hypertension-education issues. The average cost per patient was $39, which,
given that this study was published in 1981, is not comparable to the behavioral intervention
cost of more recent studies.84
Okamoto and Nakahiro performed a cost analysis in 330 patients and found no difference in
clinic visit costs between pharmacist-managed hypertension ($242.46) and physician-
managed hypertension ($233.20).85 They estimated a cost of $1.18 for each 1.0 mm Hg
reduction in systolic blood pressure. However, this study did not measure or assign costs to
any interactions between physicians and pharmacists. They also used acquisition costs for
medications that were adjusted for discounts and did not reflect real drug prices.
Two of the previously mentioned cluster randomized trials (Carter and colleagues) 46, 49 of a
pharmacist intervention were combined to evaluate cost-effectiveness.86 The study included
496 patients, 244 in the control group and 252 in the intervention group. The total time spent
by physicians in the intervention group was higher than in the control group (67.02 (SD =
46.29) vs. 53.74 (SD = 48.47) minutes, p< 0.001) due to nearly 17 minutes spent on
collaboration. Overall, pharmacists in the intervention group spent 114.34 (SD = 43.42)
minutes per patient over six months. Relative to control, the physician-pharmacist
collaboration intervention cost an average of $249.60 more per patient resulting in an
incremental cost over six months of $1,009.3 per additional patient with blood pressure
control and $26.6 per one mm Hg reduction in systolic blood pressure. The cost to achieve
goal BP in one additional patient was $1,009.30. This study was one of the most
comprehensive regarding all costs and suggested the costs of the intervention were higher
than other reports. However, the authors concluded that these costs were reasonable when
considering the presumed reductions in costs associated with avoided cardiovascular events.
Team-based interventions that used new technologies have a wide range of costs depending
on whether the technology was developed for the intervention or already in place. In the
IDEATel study telemedicine units cost $3425 (year 2002).72 However costs of telemetry
have since come down, and use existing technologies such as Skype or Face-time might be
much less costly.
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Magid did not report the cost of delivering the IVR (interactive voice recognition)
intervention.71 IVR systems vary greatly in costs, depending on the amount sophistication of
the computer model, logic systems used, and length of the interactions, and number of
follow-up attempts made if the patients is not contacted. Modem-based or Web BP telemetry
used to upload measurements from home to a data repository and collate into reports, also
incur additional costs, which are usually less than IVR, but vary mainly based on equipment
requirements.
In the Electronic Communications and Home BP Monitoring (e-BP) Trial by Green, it cost
$400 per patient to deliver the pharmacist intervention over 12 months, this included the
costs of the home BP monitors and pharmaceutical care, incremental costs and cost-
effectiveness analyses are currently being conducted. In the e-BP study the patient-shared
EHR and secure e-mail systems were already in place prior to the study and no additional
technology resources were required to deliver the Web-based pharmacist intervention.
However, for a clinic to set-up a system like this, start-up costs might be substantial. Many
of the commercially available EHRs have the capacity to add a patient Web portal or secure
e-mail, but these features costs extra money, require staff training, patient promotion, and
technical support to be fully functional. Patient-controlled EHRs generally incur no costs to
patients, but adding EHR portals, disease management applications, and secure
communications need to be paid for. Patient Web portals however can be used for a variety
of care processes, and along with the new definitions of Meaningful Use of EHRs and the
HITECH bill, provide incentives for health care systems and clinic to adopt their use.
Because of the heterogeneity of these studies it is difficult to draw any definitive
conclusions as to the cost-effectiveness of team-based interventions to improve hypertension
control or to compare costs related to type of interventionist or delivery mode. However
lessons might be gleaned from other team-based QI interventions.
Implementation of the PCMH with augmented physician-nurse and pharmacist teams led to
overall decreases in health care costs, improvement in composite quality measures, and
improved patient and physician satisfaction after 2 years.30 This study was conducted in an
integrated health care system which already had many of the resources already needed to
effectively implement collaborative care, however both nursing and pharmacist staffing was
increased to more effectively implement collaborative care. The Medicare Care
Coordination (MCC) demonstration projects, which tested the cost effectiveness of 15 care
management programs for Medicare patients with multiple co-morbidities had mostly
negative findings.87 Only 2 programs were cost-effective. Change in patient behaviors and
quality of life were minimal. Medication adherence and physiologic outcomes were not
reported. The 2 successful programs made more frequent contact with patients, taught
patients to take their medications correctly, and had more opportunities to interact directly
with the patients’ physicians. Similarly, Coleman and Wagner found that interventions to
improve chronic illness were more effective when closely integrated with the patient’s
source of primary care.88
More research on the long-term benefits and cost-effectiveness of team care interventions
are needed before the business case can be constructed and policy changed. However, it is
clear that fee-for-service clinics and physicians who do not receive re-imbursements for
using a nurse, pharmacist, or other team member, would be unlikely to be able to implement
a quality improvement program to test this model, unless they received government
subsidies, were a PCMH demonstration site, or were incentivized by being part of an
Accountable Care organization.
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The Future of team-based care for hypertension: Proposed models care
Once an intervention has been determined to be reasonable in terms of costs and
effectiveness, this leads to the question of who should pay for the intervention. Patients may
be willing to pay for the intervention if they perceive that they are receiving better care and
because of the convenience it provides. However, patients are unlikely to be willing to cover
the entire cost. Providers do not have an incentive to provide the intervention since,
currently; they are not reimbursed for it. The only environments at this time that potentially
have an incentive are capitated, integrated healthcare systems like the VA and Kaiser.
Without long-term evidence that team care decreases health care costs, insurers may have
little incentive for adopting this model. However other factors may come to bare, such as
regulatory agencies who rank plans by their success in management of chronic care
(including hypertension control), employer purchasers who might be willing to choose an
insurance product or pay more if care potentially reduces sick days. Alternatively, if patient
and physician demand exert large influence on Medicare, Medicaid, and other publically
assisted health care programs, there may be increased willingness to cover team-based care,
such as already funded by Medicare Part D that provides payment for medication therapy
management.89
The movement towards the patient-centered medical home will result in a shift from an
acute care model, or illness model, to a model for managing chronic conditions proactively
or a wellness model. Such care will not only affect the traditional team but also those who
schedule patients so that scheduling can accommodate continuity with the hypertension
management team. The team must be supported by strategies to track patients and
populations, identify patients whose BP is not controlled, remind them of their upcoming
office visit and contact them when they do not show up for an appointment. The patient-
centered medical home also requires electronic record support for patients so that they can
examine their records, have access to schedule their own appointments, email providers and
receive web-based support. The patient-centered medical home incentives made possible by
the HITECH bill, the PCMH and Accountable Care organizations provide new opportunities
for use of these technologies to enhance team care.
We propose a model in which the minimum team would be a physician, nurse or pharmacist
but should also include social workers, nutritionists, hypertension specialist, and community
health workers for specific patients. The model would include the primary care physician
who is responsible for diagnosis and evaluation of hypertension for potential secondary
causes, additional risk factors and target organ damage. The physician would also conduct
periodic physical examinations and follow-up assessments for target organ damage. If at any
point new signs or symptoms develop the physician should evaluate the patient. Highly
complex patients, those with resistant hypertension despite multiple manipulations of
appropriate therapy and those with suspected secondary causes, should be referred to the
hypertension specialist.
This proposed care model would require extensive communication between the team
members. Protocols, policies and procedures for communication, triage and referral back to
the physician so information transfers are coordinated and complete should be developed
and understood. Accurate and complete medical record documentation to support team
communication will be critical, and scalability would require the use of electronic medical
records
A nurse or pharmacist with expertise in hypertension would provide education and
counseling and probably ongoing case management for most patients, especially those who
have achieved and maintain control of their BP. Education would include thorough
discussions about all lifestyle modifications, smoking cessation and how to empower the
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patient to implement these strategies. The nutritionist, if available, would provide extensive
counseling about diet and weight loss strategies. If a nutritionist is not available, the nurse
who specializes in hypertension management can provide these services. For patients taking
BP medication, a nurse would also be able to modify medications and adjust dosages. The
pharmacist in the office could also assist with medication management, titration for patients
not at goal, designing drug and monitoring regimens for specific patients and algorithm
development for the practice. The office pharmacist could assist with management of
patients with multiple co-existing conditions, and those with complex drug regimens who
are at risk for adverse reactions and drug-drug interactions. The pharmacist could also
counsel patients about proper medication use, administration, storage and adverse reactions
that might occur. While they are not frequently considered as team members, community
pharmacists could also assist with such monitoring.33, 90, 91 Additionally electronic
communications (both telephone and Internet enabled) is likely to be an increasing part of
team-care, with home BP monitoring, behavioral support, improved access via synchronous
and asynchronous communications as a key part of improving the efficiency76, 92 and
effectiveness of hypertension care, making it possible for the team to function at separate
sites virtually.
Patients with hypertension frequently have other chronic conditions, and secondary to
increasing rates of obesity, progressively at younger ages. When multiple chronic conditions
are combined with substance abuse, poverty, low levels of education and/or low
enculturation, health outcomes worsen and care costs rise rapidly. Team care as envisioned
in the PCMH incorporates whole-person care that takes into account all of the patient’s
chronic conditions, preventive care needs, and social factors that mitigate the delivery of
optimal and efficient care. Moving from a disease-specific model to a patient-centered
model that includes team-based care is believed by many to be a key aspect of health care
reform.
SUMMARY
While this review is not exhaustive, there is strong body of evidence that teams are effective
in treating blood pressure. Team-base care provides new opportunities for hypertension care
to be more patient-centered by providing care that is more personalized, timely,
collaborative, and patient- empowering and allows physicians more time to manage more
complex and urgent issues as they arise. There is also a growing focus on the PCMH and use
of technology to improve access to care.
The challenges moving forward include not only improving access, but ensuring the access
is of high quality. Technology needs to be rigorously evaluated and not viewed as a panacea.
Further work is needed to better understand and evaluate patients’ and providers’ preference
for communication. Policy implications of team-based care will need to be addressed. For
example: how are teams and technology used to improve access to the primary care
reimbursed? What is a reasonable return on investment (ROI)? What are appropriate
indicators of cost effectiveness? and How should these constructs be evaluated? We
encourage further dialogue and research to address these issues. Additionally, much more
research is needed, to determine the effects of team-based care on specific populations,
optimal dose and intensity of interventions, and whether ongoing or booster interventions
are needed. More comparative studies are needed to determine the most efficient, effective,
and personalized methods for providing ongoing team-based care for hypertension. Results
from ongoing studies will provide important information on the refinements to this model,
lead to increased feasibility of large scale implementation, and confirm whether expected
long-term effectiveness and cost- effectiveness benefits are realized.
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Table 1
National Center on Quality Assurance (NCQA) Content and Scoring of Practices on Progress Towards the
Patient-Centered Medical Home
Standard 1: Access and Communication Points Standard 6: Test Tracking
A. Has written standards for patient
  access and communication* 4
A. Tracks tests and identifies abnormal
  results systematically** 7
B. Uses data to show it meets its
  standards for patient access and
  communication* 5
B. Uses electronic systems to order and
  retrieve tests and flag duplicate tests
6
Total points: 9 Total points: 13
Standard 2: Patient Tracking and Registry Standard 7: Referral Tracking
Functions A. Tracks referrals using paper-based
  or electronic system** 4
A. Uses data system for basic patient
  information (mostly non-clinical data) 2
Total points:
4
B. Has clinical data system with clinical
  data in searchable data fields 3
C. Uses the clinical data system 3
D. Uses paper or electronic-based
  charting tools to organize clinical
  information** 6
E. Uses data to identify important
  diagnosis and conditions in practice** 4
F. Generates lists of patients and
  reminds patients and clinicians of
  services needed (population
  management) 3
Total points: 21
Standard 3: Care Management Standard 8: Performance Reporting and
  Improvement
A. Adopts and implements evidencebased
    guidelines for three
    conditions ** 3
A. Measures clinical and/or service
  performance by physician or across
  the practice** 3
B. Generates reminders about
    preventive services for clinicians 4
B. Survey of patients’ care preferences
3
C. Uses non-physician staff to
    manage patient care 3
C. Reports performance across the
  practice or by physician** 3
D. Conducts care management,
  including care plans, assessing
  progress, addressing barriers 5
D. Sets goals and takes action to
  improve performance
3
E. Coordinates care/follow-up for
    patients who receive care in
    inpatient and outpatient facilities 5
E. Produces reports using
  standardized measures
2
F. Transmits reports with standardized
  measures electronically to external
  entities 1
Total points: 20 Total points: 15
Standard 4: Patient Self-Management Standard 9: Advanced Electronic
Support Communications
A. Assesses language preference and 2 A. Availability of Interactive Website 1
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  other communication barriers
B. Actively supports patient selfmanagement** 4 B. Electronic Patient Identification 2
C. Electronic Care Management
  Support 1
Total points: 6 Total points: t:c>
Standard 5: Electronic Prescribing Points
A. Uses electronic system to write
  prescriptions 3
B. Has electronic prescription writer with
  safety checks 3
C. Has electronic prescription writer with
  cost checks 2
Total points: 5
**
indicates Must Pass Elements; Adapted from NCQA.93
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Table 2
NCQA Scoring and Levels of Certification for the Patient Centered Medical Home
Level of Qualifying Points Must Pass Elements at 50%Performance Level
Level 3 75-100 10 of 10
Level 2 50-74 10 of 10
Level 1 25-49 5 of 10
Not recognized 0-24 <5
Levels: Level 3 is the highest level recognized by NCQA. Level is determined by the total points plus the “must pass” elements. A lower level of
recognition will be awarded if all “must pass” elements are not met, regardless of total points. Practices with a score of ≤24 or <5 “must pass”
elements will not be recognized within the context of the Patient-Centered Medical Home.93
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